GENDER DIFFERENCES IN VASCULAR ACCESS FOR PREVALENT HEMODIALYSIS PATIENTS

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/f70883f52f6411ef9cb1ab85cd02d0f7.pdf
GENDER DIFFERENCES IN VASCULAR ACCESS FOR PREVALENT HEMODIALYSIS PATIENTS

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Ramon
Roca-Tey
Ramon Roca-Tey 18647rrt@comb.cat Hospital Universitari Mollet Nephrology Mollet del Vallès Spain *
Jordi Comas jcomas@catsalut.cat Servei Català de la Salut Organització Catalana de Trasplantaments Barcelona Spain -
Amparo Roda a.roda@fsm.cat Hospital Universitari Mollet Nephrology Mollet del Vallès Spain -
Juan Carlos González-Oliva jc.gonzalez@fsm.cat Hospital Universitari Mollet Nephrology Mollet del Vallès Spain -
Jessica Ugalde-Altamirano j.ugalde@fsm.cat Hospital Universitari Mollet Nephrology Mollet del Vallès Spain -
Verónica Duarte v.duarte@fsm.cat Hospital Universitari Mollet Nephrology Mollet del Vallès Spain -
Cynthia Mercado c.mercado@fsm.cat Hospital Universitari Mollet Nephrology Mollet del Vallès Spain -
Jordi Calls j.calls@fsm.cat Hospital Universitari Mollet Nephrology Mollet del Vallès Spain -
Jaume Tort jtort@catsalut.cat Servei Català de la Salut Organització Catalana de Trasplantaments Barcelona Spain -
 
 
 
 
 
 

Gender disparities of some aspects of vascular access (VA) for hemodialysis (HD) have been reported. Aim: To analyze the VA profile of prevalent HD patients (pts) according to gender in Catalonia, Spain

Data from the Catalan Renal Registry of adult end-stage kidney disease (ESKD) pts treated by HD on 31 December were examined from 1997 to 2021.

The total cumulative number of follow-ups registered for prevalent ESKD pts treated by HD was 95,575 out of 25,130 pts; we have VA information for most of the follow-ups (93.1%, 88,980/95,575). The number of prevalent HD pts increased from 3104 in 1997 to 4270 in 2021.

 The distribution of the VA used for performing HD in 2021 was also different in men vs women: fistula AVF (58.1%, n=1465 vs 45.6%, n=657), graft (1.8%, n=45 vs 3.5%, n=51) and tunnelled catheter (35.8%, n=903 vs 45.8%, n=660) (for all comparisons, p<0.001); there were no differences for non-tunnelled catheter (4.3%, n=107 vs 5.0%, n=72) (p=0.15). In addition, the type of AVF was different in men vs women: radiocephalic AVF (53.9% vs 40.9%) and brachial artery-based AVF (46.1% vs 59.1%) (p<0.001).

 The percentage of pts who required at least one hospital admission or outpatient procedure for any VA pathology in 2021 was similar when comparing men [7.3% (n=180) and 19.6% (n=456), respectively] and women [8.6% (n=122) and 19.3% (260), respectively] (p=0.34 and p=0.38, respectively).

Regarding the total cumulative number of VA used for HD, the percentage of pts who used only one VA was higher for men (50.4%, n=1265) than women (47.1%, n=663); however, this difference is reversed when the percentage of pts who used ≥4 VA was calculated: 11.5% (n=289) vs 14.4% (n=203) (for all comparisons, p=0.001). The percentage of pts who have been dialyzed through AVF at some point over time was higher for men (69.2%, n=1889) than women (62.6%, n=964) (p<0.001)

 The probability of performing HD through AVF in 2021 was independently associated with male gender (odds ratio 1.58 [95% confidence interval: 1.36–1.82], p<0.001) after adjusting for age, time on HD, primary kidney disease, cardiovascular disease, functional status and body mass index (multivariate logistic regression analysis).

The percentage of both men and women on HD through AVF decreased progressively from 1997 (89.1% and 81.3%, respectively) to 2021 (58.1% and 45.6%, respectively) (for both comparisons, p<0.001). The percentage of prevalent men on HD with AVF was always higher over time than that of women from 1997 (89.1% vs 58.1%) to 2021 (81.3% vs 45.6%) (for both comparisons, p<0.001).

1) AVF was the main type of VA used for prevalent men on HD, but AVF and tunnelled catheter shared this ranking in women. 2) Male gender was an independent factor associated with a 58% greater probability of performing HD through AVF than female. 3) The percentage of prevalent HD pts dialyzed through AVF progressively decreased over time in both sexes but it was always higher in men than women. 4) The type of AVF mainly used was different depending on gender: radiocephalic AVF for men and brachial artery-based AVF for women. Abstract submitted at the 40th Annual Meeting of the Catalan Society of Nephrology.

Kewords